2.2Impact Factor
3.7CiteScore
27 daysTime to First Decision

Diabetology, Volume 4, Issue 3

September 2023 - 14 articles

Cover Story: The health department in Los Angeles County partnered with three health centers to implement a produce prescription program (PPR) for patients with diabetes or prediabetes. The PPR provided patients with USD 40 monthly for 6 months to purchase fresh produce. This qualitative assessment describes clinic staff experiences with the PPR, documenting the facilitators and barriers they encountered during implementation. Interviewees discussed the importance of having preexisting partnerships and programs to support the PPR at their clinics. Hidden costs related to PPR implementation included a large and unexpected amount of staff time devoted to patient enrollment. Findings can be used to inform future PPR efforts, helping to facilitate quality program delivery and troubleshoot implementation barriers. View this paper

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

Select all

Editorial

2,855 Views

4 Pages

Cutting Edge Developments in Diabetes

Peter M. Clifton

Diabetology2023, 4(3), 278-281;https://doi.org/10.3390/diabetology4030024

13 July 2023

Since 2005, glucagon-like peptide 1 (GLP-1) receptor agonists have been clinically available, which has resulted in a significant transformation in diabetes care, both in terms of weight management and glucose control [...]

Full Article

Review

8 Citations

6,628 Views

19 Pages

Preventive Epigenetic Mechanisms of Functional Foods for Type 2 Diabetes

Bilyaminu Abubakar,
Dawoud Usman,
Kamaldeen Olalekan Sanusi,
Nur Hanisah Azmi and
Mustapha Umar Imam

Diabetology2023, 4(3), 259-277;https://doi.org/10.3390/diabetology4030023

4 July 2023

Type 2 diabetes (T2D) is a growing global health problem that requires new and effective prevention and management strategies. Recent research has highlighted the role of epigenetic changes in the development and progression of T2D, and the potential...

Full Article

Commentary

9 Citations

3,441 Views

8 Pages

Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms

Andrej Belančić and
Sanja Klobučar

Diabetology2023, 4(3), 251-258;https://doi.org/10.3390/diabetology4030022

4 July 2023

Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been linked to beneficial effects on cardiovascular risk factors, blood pressure, body weight, and lipid profile, according to a substantial body of literature. Significant cardiac and renal ben...

Full Article

Opinion

1 Citations

4,883 Views

8 Pages

Dietary Sugars during Critical Phases of Development and Long-Term Risk of Non-Communicable Diseases

Marcos Divino Ferreira-Junior,
Keilah Valéria Naves Cavalcante,
Ariel Penha Carvalho da Mota and
Rodrigo Mello Gomes

Diabetology2023, 4(3), 243-250;https://doi.org/10.3390/diabetology4030021

25 June 2023

Obesity and the intake of high-sugar diets have dramatically increased in recent decades. However, it is still uncertain how sugar intake during the critical development phase affects the long-term health of children. In this context, the Development...

Full Article

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Diabetology - ISSN 2673-4540

Imprint

Download Flyer